AIDS news from FierceVaccines
NewsFeds steering funds back to basic AIDS vax research
After trying and failing repeatedly to develop an AIDS vaccine, federal officials say they're going back to the drawing board to come up with some new ideas. Read more...
Insurance fears make volunteers balk at AIDS trial
A professor at the University of Toronto is warning that researchers may find it increasingly difficult to enlist volunteers for new trials exploring the safety and efficacy of experimental AIDS Read more...
| Press ReleasesPRESS RELEASE: FDA Advisory Committee Unanimously Recommends Accelerated Approval of ISENTRESS FDA Advisory Committee Unanimously Recommends Accelerated Approval of ISENTRESS™ (raltegravir), Merck's Investigational Oral Integrase Inhibitor, for Treatment of HIV WHITEHOUSE STATION, N.J., Read more... |
Get more AIDS coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight